Correction to: Nature Protocols https://doi.org/10.1038/s41596-020-0379-4, published online 14 September 2020.
In the version of this article initially published, the ‘Reagent setup’ section contained two errors. First, the final concentration for CHIR-99021 was incorrectly given as 3 µM; the correct concentration is 0.3 μM. Second, the instructions for preparing the PGE2 solution said to dissolve 1 mg of PGE2; the sentence should have read ‘Dissolve 10 mg of PGE2 in 2.84 ml of DMSO to make a 10 mM stock solution.’
The errors have been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Driehuis, E., Kretzschmar, K. & Clevers, H. Author Correction: Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc 16, 5739 (2021). https://doi.org/10.1038/s41596-021-00494-5
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41596-021-00494-5
This article is cited by
-
Impact of enzymatic isolation on the propagation efficiency of patient-derived colorectal cancer organoids
Scientific Reports (2025)
-
Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets
Genes & Genomics (2025)
-
The use of organoids in creating immune microenvironments and treating gynecological tumors
Journal of Translational Medicine (2024)
-
Progress and promise of alternative animal and non-animal methods in biomedical research
Archives of Toxicology (2023)